Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects ofSF3B1mutations

Author:

Pacholewska AlicjaORCID,Lienhard MatthiasORCID,Brüggemann MirkoORCID,Hänel Heike,Bilalli Lorina,Königs Anja,Becker KerstinORCID,Köhrer Karl,Kaiser Jesko,Gohlke Holger,Gattermann NorbertORCID,Hallek MichaelORCID,Herling Carmen D.,König JulianORCID,Grimm ChristinaORCID,Herwig RalfORCID,Zarnack KathiORCID,Schweiger Michal R.ORCID

Abstract

AbstractBackgroundMutations in splicing factor 3B subunit 1 (SF3B1) frequently occur in patients with chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDS). These mutations have a different effect on the disease prognosis with beneficial effect in MDS and worse prognosis in CLL patients. A full-length transcriptome approach can expand our knowledge onSF3B1mutation effects on RNA splicing and its contribution to patient survival and treatment options.ResultsWe applied long-read transcriptome sequencing to 44 MDS and CLL patients with and withoutSF3B1mutations and found > 60% of novel isoforms. Splicing alterations were largely shared between cancer types and specifically affected the usage of introns and 3’ splice sites. Our data highlighted a constrained window at canonical 3’ splice sites in which dynamic splice site switches occurred inSF3B1-mutated patients. Using transcriptome-wide RNA binding maps and molecular dynamics simulations, we showed multimodal SF3B1 binding at 3’ splice sites and predicted reduced RNA binding at the second binding pocket of SF3B1K700E.ConclusionsOur work presents the hitherto most complete long-read transcriptome sequencing study in CLL and MDS and provides a resource to study aberrant splicing in cancer. Moreover, we showed that different disease prognosis results most likely from the different cell types expanded during cancerogenesis rather than different mechanism of action of the mutatedSF3B1. These results have important implications for understanding the role ofSF3B1mutations in hematological malignancies and other related diseases.HighlightsLong-read transcriptome sequencing data enables the identification of > 60% of novel isoforms in the transcriptomes of CLL and MDS patients and isogenic cell lines.SF3B1mutations trigger common splicing alterations uponSF3B1mutations across patient cohorts, most frequently decreased intron retention and increased alternative 3’ splice site usage.Mutation effect depends on alternative 3’ splice site and branch point positioning that coincide with bimodal SF3B1 binding at these sitesMolecular dynamics simulations predict reduced binding of SF3B1K700Eto mRNA at the second binding pocket harboring the polypyrimidine tract.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3